Advertisement
Screener

Synergy CHC Corp. (SNYR) Current Ratio

Synergy CHC Corp. (SNYR) Current Ratio

  • Current ratio · latest quarter: Value 0.93×; Formula and calculation Current assets / current liabilities..

Current ratio

Overview →

Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Current ratio · latest quarter0.93×Current assets / current liabilities.

$6.34M ÷ $6.85M ≈ 0.93×

Calculation inputs

InputAmount with unitRaw financial data
Current assets6.34M USDAssets, Current
Current obligations6.85M USDLiabilities, Current
Cash and equivalents292.12K USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Customer receivables1.27M USDAccounts Receivable, after Allowance for Credit Loss, Current
Inventory3.38M USDInventory, Net
Payables(m)Accounts Payable, Current
Borrowing debt due within one year(m)Long-term Debt, Current Maturities

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCurrent assets (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory (USD)Payables (USD)Borrowing debt due within one year (USD)Current ratio
2026-03-31$6.34M$6.85M$292.12K(m)$1.27M$3.38M(m)(m)0.93×
2025-12-31$10.01M$8.24M$2.62M(m)$3.20M$3.74M(m)(m)1.22×
2025-09-30$20.51M$3.83M$1.01M(m)$6.81M$2.15M(m)(m)5.35×
2025-06-30$19.51M$7.13M$1.46M(m)$7.07M$2.36M(m)(m)2.74×
2025-03-31$15.41M$8.07M$177.88K(m)$4.38M$2.35M(m)(m)1.91×
2024-12-31$16.06M$17.18M$687.92K(m)$5.32M$1.72M(m)$4.00M0.93×
2024-09-30$11.85M$18.25M$259.38K(m)$4.07M$1.91M(m)$6.99M0.65×
2023-12-31$11.82M$14.02M$632.53K(m)$2.11M$3.73M(m)(m)0.84×
2020-03-31$5.36M$9.80M$314.93K(m)$3.04M$1.71M(m)$5.49M0.55×
2019-12-31$5.05M$10.15M$1.22M(m)$1.42M$1.86M(m)$5.47M0.50×
2019-09-30$6.46M$10.45M$1.39M(m)$1.90M$2.23M(m)(m)0.62×
2019-06-30$7.03M$7.08M$1.06M(m)$2.37M$2.49M(m)(m)0.99×
2019-03-31$8.67M$8.83M$688.84K(m)$4.34M$2.67M(m)(m)0.98×
2018-12-31$8.94M$10.41M$459.74K(m)$4.46M$2.67M(m)(m)0.86×
2018-09-30$7.92M$5.09M$1.61M(m)$2.02M$3.38M(m)(m)1.55×
2018-06-30$9.17M$6.62M$865.81K(m)$4.09M$3.16M(m)(m)1.39×
2018-03-31$9.73M$6.48M$1.69M(m)$3.85M$3.25M(m)(m)1.50×
2017-12-31$10.41M$7.14M$1.96M(m)$4.33M$2.84M(m)(m)1.46×
2017-09-30$11.66M$6.80M$5.41M(m)$2.58M$2.10M(m)(m)1.72×
2017-06-30$4.89M$7.21M$894.23K(m)$1.45M$1.01M(m)(m)0.68×
2017-03-31$7.15M$9.53M$1.71M(m)$3.23M$740.62K(m)(m)0.75×
2016-12-31$7.26M$12.21M$2.52M(m)$2.20M$1.10M(m)$750.00K0.60×
2016-09-30$8.79M$11.28M$4.22M(m)$1.89M$986.54K$7.50K$750.00K0.78×
2016-06-30$6.16M$10.96M$3.01M(m)$978.58K$807.84K$11.39K$750.00K0.56×
2016-03-31$6.72M$11.01M$3.76M(m)$1.62M$676.84K$67.25K$750.00K0.61×
2015-12-31$9.34M$15.37M$3.64M(m)$3.98M$686.65K(m)$750.00K0.61×
2015-09-30$2.95M$2.70M$824.95K(m)$1.33M$499.45K(m)$750.00K1.09×
2015-06-30$2.99M$2.31M$637.24K(m)$1.72M$391.13K(m)$750.00K1.29×
2015-03-31$3.86M$2.47M$1.72M(m)$1.95M$133.45K(m)$751.60K1.56×
2014-12-31$55.38K$181.04K$338.00(m)$2.90K$26.06K(m)$6.40K0.31×
2013-12-31$3.23K$16.05K$3.23K(m)(m)(m)(m)(m)0.20×
2013-07-31$33.91K$23.69K$33.91K(m)(m)(m)(m)(m)1.43×

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Functional Brands Inc. (MEHA)United States$0.001B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
MANNATECH INC (MTEX)United States$0.014B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87